OPTIMA PHARMA
Open bankruptcyA bankruptcy procedure is open for OPTIMA PHARMA according to publications in the Belgian State Gazette; curator: VINCENT TERLINDEN.
Summary
The 2020 annual accounts show equity of €459k and a net result of €398k.
Signals
Two signals.
+raises risk
Checked, nothing found (1)
Financials · fiscal year 2020, full schema
Turnover
€324k
EBIT margin
66.0%
Net result
€398k▲ 858%
2019 · €42k
2018: €210k
2019: €42k
2018 → 2020
Working capital
€409k▲ 1,813%
2019 · €21k
2018: €-16k
2019: €21k
2018 → 2020
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line201820192020Trend
Turnover€324k-
Equity€19k-€60k▲ 214%€459k▲ 667%
Operating result€214k-€69k▼ 67.9%€553k▲ 705%
Net result€210k-€42k▼ 80.2%€398k▲ 858%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2020; 2020 is 705% above 2019 and is the highest result in the available series.
Balance-sheet composition
2020 in colour, 2019 as the grey bar beneath
Assets €6.65M
Fixed assets
€50k ▲ 28.4%
Current assets
€6.60M ▲ 2,454%
Equity and liabilities €6.65M
Equity
€459k ▲ 667%
Debt
€6.19M ▲ 2,504%
Debt's share of the balance-sheet total rises from 79.9% to 93.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€554k
Cash flow
€400k
Current ratio
1.07▼
2019 · 1.09
Quick ratio
1.06▼
2019 · 1.09
Debt to equity
13.48
ROE
86.8%▲
2019 · 69.5%
ROA
6.0%▼
2019 · 14.0%
Interest coverage
247.78
Debt ≤ 1 year
€6.19M▲
2019 · €237k
Income taxes
€156k▲
2019 · €25k
Staff costs
€111k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2020 against 2019 · 44 lines
Balance sheet
Code20192020
Assets
Total assets20/58€297k€6.65M▲
Fixed assets21/28€39k€50k▲
Tangible fixed assets22/27-€8k
Furniture and vehicles24-€8k
Financial fixed assets28€39k€42k▲
Current assets29/58€258k€6.60M▲
Amounts receivable after more than one year29-€70k
Trade receivables290-€70k
Stocks and contracts in progress3-€30k
Stocks30/36-€30k
Amounts receivable within one year40/41€187k€6.30M▲
Trade receivables40-€5.93M
Other amounts receivable41-€370k
Current investments50/53-€81k
Cash at bank and in hand54/58€153€118k▲
Deferred charges and accrued income490/1-€55
Equity and liabilities
Total equity and liabilities10/49€297k€6.65M▲
Equity10/15€60k€459k▲
Contributions10/11€6k€6k=
Profit (loss) carried forward14€54k€453k▲
Amounts payable17/49€238k€6.19M▲
Amounts payable within one year42/48€237k€6.19M▲
Trade debts44€46k€5.68M▲
Suppliers440/4-€5.68M
Taxes, remuneration and social security45-€407k
Taxes450/3-€384k
Remuneration and social security454/9-€23k
Other amounts payable47/48-€97k
Income statement
Code20192020
Remuneration, social security and pensions62-€111k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€2k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€216k
Gross operating margin9900€103k€881k▲
Operating profit (loss)9901€69k€553k▲
Financial income75/76B-€4k
Recurring financial income75€5k€4k▼
Financial charges65/66B-€2k
Recurring financial charges65€7k€2k▼
Profit (loss) for the period before taxes9903€67k€554k▲
Income taxes67/77€25k€156k▲
Profit (loss) for the period9904€42k€398k▲
Profit (loss) for the period to be appropriated9905€42k€398k▲
Appropriation of the result
Profit (loss) to be appropriated9906-€453k
Profit (loss) brought forward from the previous period14P-€54k
Return on contributions (dividend)694€808-
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2022
02-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 306 days late
2021
18-11
Bankruptcy
Opening
Tribunal de l’entreprise francophone de Bruxelles · OPTIMA PHARMA SRL AVENUE GEORGES LECOINTE 50, 1180 UCCLE · event 15-11-2021
2020
31-12
Financial
Highest result since 2018net €398k ▲858%
Operating result €553k, net result €398k, both a record.
31-12
Financial
Equity above €200kEq €459k ▲667%
3 profitable years in a row build equity to €459k.
25-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 25 days late
2019
31-12
Financial
Weakest financial yearnet €42k ▼80.2%
Net result drops to €42k, the lowest in the series.
14-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 75 days late
2018
27-11
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 119 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
2016
07-11
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 99 days late
2015
22-07
NBB filing
Annual accounts filed
fiscal year 2014 · full schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Georges Lecointelaan 501180 UkkelGround area
2,238 m²
Building footprint
362 m²
Volume, LiDAR
2,719 m³
Parcel 21612D0103/00Z009, Brussels · tallest building 14.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Georges Lecointelaan 50, 1180 Ukkel
since 20142.233.013.046
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21612D0103/00Z009 | Brussels | 2,238 m² | 1 · 362 m² | 14.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Insolvency mandates
1 mandate| Role | Name | Tenure |
|---|---|---|
| Curator | VINCENT TERLINDEN Avenue Louise 349/16,
1050 BRUXELLES 5 |
15-11-2021 → present |
Similar companies · same sector, comparable size
ANDREX
BE 0879.257.290
Etterbeek · Eq €458,895
MCi
BE 0895.427.289
Frasnes-lez-Anvaing · Eq €458,619
MSTE Tuin Bos en Grondwerken
BE 0734.562.291
Evergem · Eq €459,843
NEW ASA
BE 0684.591.851
Morlanwelz · Eq €457,486
KJM
BE 0824.683.904
Kapellen · Eq €457,402
Of 15,529 companies in sector 43990 we hold annual accounts for 7,423. 4,721 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded03-01-2014
Fiscal year end31-12
Activities, NACEBEL 2025
43990Other specialised construction activities
73300Public relations and communication consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.